Skip to main content
. Author manuscript; available in PMC: 2012 Aug 2.
Published in final edited form as: Cancer Chemother Pharmacol. 2010 Mar 4;66(6):1087–1093. doi: 10.1007/s00280-010-1266-4

Table 2.

Prior therapies

Prior therapies No. of pts (n = 30) %
Cytotoxics
 5-fluorouracil 23 77
 Taxanes 17 57
 Irinotecan 16 53
 Capecitabine 12 40
 Anthracyclines 11 37
 Oxaliplatin/Cisplatin/Carboplatin 10/3/6 33/10/20
 Cyclophosphamide 7 23
 Gemcitabine 6 20
 Navelbine 5 17
 Other 3 10
Targeted agents
 Bevacizumab 14 47
 Cetuximab and Panitumamab (Vecitibix) 11 37
 Cetuximab 8 27
 Herceptin 4 13
 Gefitinib/Lapatinib 2/2 7/7
 Other 10 33
Hormonal therapy
 Tamoxifen 4 13
 Arimidex 5 17
 Other 4 13